Quantcast

Latest Attention-deficit hyperactivity disorder controversies Stories

2011-05-09 07:00:00

FLORHAM PARK, N.J., May 9, 2011 /PRNewswire/ -- Shionogi Inc., the U.S.-based group company of Shionogi & Co., Ltd., today announced the publication in Pediatrics of data demonstrating the efficacy of non-stimulant KAPVAY(TM) (clonidine hydrochloride) extended-release tablets when combined with stimulant medications for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents (6-17 years). This study, the first to evaluate KAPVAY in combination with...

2011-05-05 22:05:01

Difficulty with self-regulation that characterizes ADHD can extend to emotional control for some A subgroup of adults with attention-deficit hyperactivity disorder (ADHD) also exhibit excessive emotional reactions to everyday occurrences, and this combination of ADHD and emotional reactivity appears to run in families. A study from a Massachusetts General Hospital (MGH)-based research team finds that siblings of individuals with both ADHD and deficient emotional self-regulation (DESR) had a...

2011-04-25 07:33:00

WARREN, N.J., April 25, 2011 /PRNewswire/ -- MonoSol Rx, LLC ("MonoSol Rx"), the developer of PharmFilm® drug delivery technology, today announced that the Company has entered into a development and commercialization partnership with KemPharm, a biopharmaceutical company focused on the discovery and development of new, safer therapies for the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), pain, and cardiovascular disease. Under terms of the agreement, the...

2011-04-22 12:58:53

Humans are not born as blank slates for nature to write on. Neither are they behaving on genes alone. Research by Lee A. Thompson, chair of Case Western Reserve University's Psychological Sciences Department, and colleagues found that the link between Attention-Deficit/Hyperactivity Disorder (ADHD) and academic performance involves a complex interaction of genes and environment. Genetic influence was found to be greater on reading than for math, while shared environment (e.g., the home and/or...

79c387277e98069442b4eadafab9d1711
2011-04-20 12:45:00

According to a new study from Sweden, the earlier babies are born, the more likely they are to later get a prescription for ADHD medication. Researchers said that they found that babies born as little as three weeks before their due dates had an elevated risk for attention deficit hyperactivity disorder (ADHD). The authors said that the findings suggest that mothers considering scheduling cesarean births a few weeks early reconsider and deliver as close to term as possible. People with ADHD...

2011-03-16 00:00:31

Sunset Bay Academy Informs on Attention-Deficit Hyperactivity Disorder (ADHD), also known as Attention Deficit Disorder, and how this problem may cause teenagers to have difficulties in their social relationships and school performance. San Diego, CA (Vocus/PRWEB) March 15, 2011 As parents of a troubled teen we must take into consideration that nowadays one of the most significant teen problems is Attention-Deficit Hyperactivity Disorder (ADHD), also known as Attention Deficit Disorder...

2011-03-02 00:00:27

Director of National Center for Girls and Women with ADD/ADHD Reviews Best-selling Program Westbrook, Maine (Vocus/PRWEB) March 01, 2011 For most parents, the luxury of having an expert in their home to help them deal with their ADD/ADHD child is completely out of reach"”yet that is precisely what they need most. ADHD specialist and Director of the National Center for Girls and Women with ADHD, Patricia O. Quinn, MD, noted in her favorable analysis of The Total Transformation Program,...

2011-03-01 14:02:47

A new study in the March 1 issue of the journal SLEEP indicates that the ability of children with attention deficit hyperactivity disorder to remain vigilant and attentive deteriorated significantly after losing less than one hour of nightly sleep for a week.  The study suggests that even moderate reductions in sleep duration can affect neurobehavioral functioning, which may have a negative impact on the academic performance of children with ADHD. Results of multivariate analyses of...

2011-02-28 08:00:00

PHILADELPHIA, Feb. 28, 2011 /PRNewswire/ -- Shire plc, (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) approved the use of once-daily INTUNIV® (guanfacine) Extended-Release Tablets as adjunctive therapy to stimulants for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents ages 6 to 17 as part of a total treatment program. The approval is based...

2011-02-28 07:59:00

PHILADELPHIA, February 28, 2011 /PRNewswire-FirstCall/ -- Shire plc, (http://www.shire.com/shireplc/en/home ) (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) approved the use of once-daily INTUNIV(R) (guanfacine) Extended-Release Tablets (http://www.intuniv.com/) as adjunctive therapy to stimulants for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents ages 6...


Word of the Day
penuche
  • A fudgelike confection of brown sugar, cream or milk, and chopped nuts.
'Penuche' is a variant of 'panocha,' a coarse grade of sugar made in Mexico. 'Panocha' probably comes from the Spanish 'panoja, panocha,' ear of grain.
Related